NCCN 2025
Advertisement
Rettig spoke about the nuances of navigating grief and death in nursing while balancing self-care and coping.
Researchers analyzed clinical outcomes because hematopoietic SCT is becoming more a more accessible and utilized treatment.
Research presented at the NCCN Annual Conference illuminated patient experiences with tyrosine kinase inhibitors.
Researchers assessed the cost effectiveness of ibrutinib, acalabrutinib, and zanubrutinib in multiple treatment settings.
A study presented at the NCCN Annual Conference shed light on the perspectives of patients and healthcare professionals.
The presentation focused on how ambulatory care models shape patient outcomes, nursing roles, and continuing education.
Researchers investigated underlying drivers of HRQOL degradation in CLL, including muscle weakness and fatigue.
The program will feature nursing perspectives on patient access, finances in cancer care, and holistic self-care for nurses.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.